• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.

作者信息

Teschendorf H J, Kretzschmar R, Kreiskott H, Weifenbach H

出版信息

Arzneimittelforschung. 1981;31(9a):1580-8.

PMID:7197973
Abstract

4-Amino-6-methoxy-1-phenyl-pyridazinium methyl sulfate (ameziniummetilsulfate, LU 1631, Regulton), in this study briefly called amezinium, was tested for possible central effects taking particular account of the mechanisms of action found for this substance in other studies. 1. The most conspicuous action of amezinium was in modifying reserpine-induced ptosis and reserpine-induced hypothermia. When amezinium is given before reserpine, the ED50 values are 0.15 and 3.9 mg/kg p.o. for both mouse and rat. These effects can be explained by a peripheral site of action since peripheral sympathomimetic effects can also be demonstrated in this dose range. Higher doses (10 mg/kg and upwards p.o.) were required to abolish reserpine-induced hypothermia 17 h after reserpine administration, an effect which probably requires a central site of action. But for imipramine, desipramine and pargyline the effective doses are the same in both experimental models (administration before and after reserpine, respectively). 2. Amezinium potentiated the effect of a threshold dose of L-dopa. Based on the central symptoms, higher doses (10 mg/kg p.o.) were also required for this effect. 3. With blood pressure increasing doses, the sleeping-waking pattern was modified in that duration and number of REM-episodes were reduced; in cats there was no parallel increase of wakefulness whilst in rats there was a slight relative increase of wakefulness. 4. Amezinium, particularly at high doses (46.4 mg/kg and upwards), exhibited a central depressant effect on the spontaneous behaviour of mice and rats and on orientational hyperactivity of mice. Based on the modification of aggregation toxicity, the effect of methamphetamine was reduced. In no dose range was there any evidence of methamphetamine-like effects (increase of motor activity, inhibition of food intake and increase of aggregation toxicity). 5. Amezinium did not affect the duration of hexobarbital anaesthesia or the coordination of mice on a rotating rod. 6. The acute toxicity of amezinium in mice and rats was low. The oral LD50 for mice was 1630 mg/kg and for rats 1410 mg/kg.

摘要

相似文献

1
Pharmacology of amezinium, a novel antihypotensive drug. VI. Effect on central nervous functions.
Arzneimittelforschung. 1981;31(9a):1580-8.
2
Pharmacology of amezinium, a novel antihypotensive drug. III. Studies on the mechanism of action.新型抗低血压药物阿米洛利的药理学。III. 作用机制研究。
Arzneimittelforschung. 1981;31(9a):1558-65.
3
Haemodynamic effects of amezinium in man.
Arzneimittelforschung. 1981;31(9a):1638-46.
4
Pharmacology of amezinium, a novel antihypotensive drug. IV. Biochemical investigations of the mechanism of action.
Arzneimittelforschung. 1981;31(9a):1566-74.
5
General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.盐酸N-(2,6-二甲基苯基)-8-吡咯烷乙酰胺半水合物的一般药理学研究。首次通讯:对中枢神经系统的作用。
Arzneimittelforschung. 1988 Oct;38(10):1398-409.
6
Pharmacokinetics of amezinium in rat and dog.
Arzneimittelforschung. 1981;31(9a):1594-604.
7
General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
Arzneimittelforschung. 1990 Feb;40(2 Pt 1):225-31.
8
Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine.
Arzneimittelforschung. 1981;31(9a):1647-52.
9
General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.贝前列素钠的一般药理学。首次通讯:对中枢神经系统的作用
Arzneimittelforschung. 1989 Aug;39(8):860-6.
10
The fate of amezinium in humans and animals.阿美铵在人和动物体内的代谢情况。
Arzneimittelforschung. 1981;31(9a):1616-22.